TNFAIP3 and B-cell non-Hodgkin lymphoma: Additionally, the mutation of TNFAIP3 has been widely studied in B-cell lymphoma [13, 16, 31], but its mutation pattern and impact on the prognosis of TCL patients are little known [15].